These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 760018)

  • 1. Estrogen and progestin binding in cytosols of ovarian adenocarcinomas.
    Holt JA; Caputo TA; Kelly KM; Greenwald P; Chorost S
    Obstet Gynecol; 1979 Jan; 53(1):50-8. PubMed ID: 760018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen receptor and peroxidase activity in epithelial ovarian carcinomas.
    Holt JA; Lyttle CR; Lorincz MA; Stern SD; Press MF; Herbst AL
    J Natl Cancer Inst; 1981 Aug; 67(2):307-18. PubMed ID: 6943370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of estrogen and progesterone receptors and the dissociated regulation of growth and progesterone receptor stimulation by estrogen in MDA-MB-134 human breast cancer cells.
    Reiner GC; Katzenellenbogen BS
    Cancer Res; 1986 Mar; 46(3):1124-31. PubMed ID: 3943090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Androgen, estrogen and progestin binding in cytosols of benign gynecologic tumors and tumor-like lesions.
    Punnonen R; Pettersson K; Vanharanta R; Lukola A
    Horm Metab Res; 1985 Nov; 17(11):607-9. PubMed ID: 4077024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Steroid-hormone-binding proteins in normal and neoplastic mammary tissues from C3H mice fed diethylstilbestrol.
    Lewko WM; Wittliff JL
    J Toxicol Environ Health; 1983 Jul; 12(1):127-41. PubMed ID: 6632000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of tamoxifen on steroid hormone receptors and hormone concentration and the results of DNA analysis by flow cytometry in endometrial carcinoma.
    Nola M; Jukić S; Ilić-Forko J; Babić D; Uzarević B; Petrovecki M; Suchanek E; Skrablin S; Dotlić S; Marusić M
    Gynecol Oncol; 1999 Mar; 72(3):331-6. PubMed ID: 10053103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of estrogen and progestin receptor concentrations in an experimental rat prostatic carcinoma by estrogen, antiestrogen, and progesterone.
    Mobbs BG; Johnson IE; DeSombre ER; Toth J; Hughes A
    Cancer Res; 1987 May; 47(10):2645-51. PubMed ID: 3552202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen and progestin regulate metastasis through the PI3K/AKT pathway in human ovarian cancer.
    Hua K; Feng W; Cao Q; Zhou X; Lu X; Feng Y
    Int J Oncol; 2008 Nov; 33(5):959-67. PubMed ID: 18949358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytosol and nuclear estrogen and progestin receptors and 17 beta-hydroxysteroid dehydrogenase activity in non-diseased tissue and in benign and malignant tumors of the human ovary.
    Vierikko P; Kauppila A; Vihko R
    Int J Cancer; 1983 Oct; 32(4):413-22. PubMed ID: 6311758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen receptors in ovarian epithelial carcinoma.
    Schwartz PE; LiVolsi VA; Hildreth N; MacLusky NJ; Naftolin FN; Eisenfeld AJ
    Obstet Gynecol; 1982 Feb; 59(2):229-38. PubMed ID: 7078869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of estrogen and progestin receptors in ovarian cancer.
    Kauppila A; Vierikko P; Kivinen S; Stenbäck F; Vihko R
    Obstet Gynecol; 1983 Mar; 61(3):320-6. PubMed ID: 6823373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. WT1, estrogen receptor, and progesterone receptor as markers for breast or ovarian primary sites in metastatic adenocarcinoma to body fluids.
    Lee BH; Hecht JL; Pinkus JL; Pinkus GS
    Am J Clin Pathol; 2002 May; 117(5):745-50. PubMed ID: 12090423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resistance to tamoxifen with persisting sensitivity to estrogen: possible mediation by excessive antiestrogen binding site activity.
    Pavlik EJ; Nelson K; Srinivasan S; Powell DE; Kenady DE; DePriest PD; Gallion HH; van Nagell JR
    Cancer Res; 1992 Aug; 52(15):4106-12. PubMed ID: 1638522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody-recognized [125I]estradiol-receptor complex in ovarian epithelial carcinoma.
    Holt JA; Lorincz MA; King WJ
    Obstet Gynecol; 1983 Aug; 62(2):231-5. PubMed ID: 6866366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cytosol estrogen and progesterone receptors in female genital system malignant tumors].
    Han SW; He B; Tang QP
    Zhonghua Fu Chan Ke Za Zhi; 1994 Jan; 29(1):12-5, 59. PubMed ID: 8033616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histopathologic correlations of estrogen and progestin receptor protein in epithelial ovarian carcinomas.
    Schwartz PE; Merino MJ; Livolsi VA; Lawrence R; MacLusky N; Eisenfeld A
    Obstet Gynecol; 1985 Sep; 66(3):428-33. PubMed ID: 4022502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of estrogen receptor levels in endometrial cancer cells.
    Gurpide E; Blumenthal R; Fleming H
    Prog Clin Biol Res; 1984; 142():145-65. PubMed ID: 6709655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions of antiestrogens with human breast cancer in long-term tissue culture.
    Lippman M; Bolan G; Huff K
    Cancer Treat Rep; 1976 Oct; 60(10):1421-9. PubMed ID: 1035504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved measurement of androgen receptors in human breast cancer.
    Lea OA; Kvinnsland S; Thorsen T
    Cancer Res; 1989 Dec; 49(24 Pt 1):7162-7. PubMed ID: 2582456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of estradiol on estrogen receptor, progesterone receptor, and tyrosinase in hamster melanoma transplanted into athymic mice.
    Hitselberger MH; Schleicher RL; Beattie CW
    Cancer Res; 1988 Jul; 48(13):3720-7. PubMed ID: 3132319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.